 Sukumar Vijayaraghavan
Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 11 | 2018 | 273 | 2.660 |
Why?
| | Olfactory Bulb | 6 | 2018 | 123 | 2.290 |
Why?
| | Acetylcholine | 5 | 2015 | 166 | 1.120 |
Why?
| | Synaptic Transmission | 5 | 2011 | 227 | 0.960 |
Why?
| | Calcium | 7 | 2015 | 1089 | 0.830 |
Why?
| | Neurons | 7 | 2015 | 1277 | 0.730 |
Why?
| | Action Potentials | 5 | 2015 | 406 | 0.680 |
Why?
| | Excitatory Postsynaptic Potentials | 6 | 2018 | 98 | 0.670 |
Why?
| | Interneurons | 2 | 2018 | 96 | 0.610 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2015 | 144 | 0.560 |
Why?
| | Pyramidal Cells | 3 | 2011 | 51 | 0.500 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 527 | 0.470 |
Why?
| | Synaptic Potentials | 1 | 2013 | 17 | 0.430 |
Why?
| | Receptors, Presynaptic | 2 | 2003 | 5 | 0.400 |
Why?
| | Olfactory Nerve | 1 | 2012 | 9 | 0.400 |
Why?
| | Mossy Fibers, Hippocampal | 2 | 2009 | 5 | 0.390 |
Why?
| | Cholinergic Neurons | 1 | 2011 | 15 | 0.380 |
Why?
| | Mice, Transgenic | 3 | 2017 | 1947 | 0.370 |
Why?
| | Neural Inhibition | 2 | 2015 | 139 | 0.350 |
Why?
| | Neuronal Plasticity | 2 | 2009 | 207 | 0.340 |
Why?
| | Synapses | 2 | 2015 | 331 | 0.340 |
Why?
| | CA3 Region, Hippocampal | 1 | 2009 | 4 | 0.330 |
Why?
| | Dentate Gyrus | 1 | 2009 | 29 | 0.330 |
Why?
| | Astrocytes | 3 | 2009 | 159 | 0.310 |
Why?
| | Receptors, Cholinergic | 2 | 2015 | 41 | 0.310 |
Why?
| | Neuroglia | 1 | 2009 | 149 | 0.300 |
Why?
| | Animals | 19 | 2018 | 31565 | 0.300 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2008 | 98 | 0.290 |
Why?
| | Central Nervous System Diseases | 1 | 2008 | 60 | 0.280 |
Why?
| | Drug Design | 1 | 2008 | 147 | 0.270 |
Why?
| | Hippocampus | 4 | 2011 | 690 | 0.270 |
Why?
| | Glutamic Acid | 2 | 2009 | 210 | 0.260 |
Why?
| | Calcium Signaling | 3 | 2018 | 213 | 0.260 |
Why?
| | Signal Transduction | 3 | 2015 | 4501 | 0.250 |
Why?
| | Rats, Sprague-Dawley | 7 | 2017 | 2182 | 0.240 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 3 | 2011 | 95 | 0.240 |
Why?
| | Rats | 8 | 2009 | 4913 | 0.230 |
Why?
| | Mice | 7 | 2018 | 14843 | 0.230 |
Why?
| | Endoplasmic Reticulum | 1 | 2005 | 234 | 0.220 |
Why?
| | Patch-Clamp Techniques | 2 | 2015 | 239 | 0.200 |
Why?
| | Models, Neurological | 2 | 2015 | 212 | 0.200 |
Why?
| | Choline O-Acetyltransferase | 2 | 2011 | 23 | 0.190 |
Why?
| | Adenosine Triphosphate | 3 | 2009 | 428 | 0.180 |
Why?
| | Substance-Related Disorders | 1 | 2009 | 942 | 0.180 |
Why?
| | Presynaptic Terminals | 3 | 2009 | 55 | 0.180 |
Why?
| | Staining and Labeling | 2 | 2011 | 134 | 0.170 |
Why?
| | Neurotransmitter Agents | 3 | 2009 | 75 | 0.160 |
Why?
| | Feedback, Physiological | 1 | 2018 | 68 | 0.150 |
Why?
| | Refractometry | 1 | 2017 | 27 | 0.140 |
Why?
| | Optical Imaging | 1 | 2017 | 52 | 0.140 |
Why?
| | Supraoptic Nucleus | 2 | 2006 | 4 | 0.140 |
Why?
| | Fluorescent Dyes | 3 | 2009 | 298 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 511 | 0.110 |
Why?
| | Behavior, Animal | 2 | 2015 | 459 | 0.110 |
Why?
| | Receptors, Glutamate | 1 | 2013 | 18 | 0.110 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 684 | 0.110 |
Why?
| | Nervous System | 2 | 2011 | 63 | 0.100 |
Why?
| | Animals, Newborn | 2 | 2008 | 777 | 0.100 |
Why?
| | Fura-2 | 2 | 2009 | 19 | 0.100 |
Why?
| | Cells, Cultured | 4 | 2005 | 3861 | 0.100 |
Why?
| | Transgenes | 2 | 2011 | 170 | 0.100 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2012 | 28 | 0.100 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 370 | 0.100 |
Why?
| | Nicotinic Antagonists | 1 | 2011 | 20 | 0.090 |
Why?
| | Nicotine | 2 | 2003 | 265 | 0.090 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 4680 | 0.090 |
Why?
| | Indicators and Reagents | 1 | 2009 | 99 | 0.080 |
Why?
| | Receptors, Drug | 1 | 2009 | 12 | 0.080 |
Why?
| | Organ Culture Techniques | 1 | 2009 | 140 | 0.080 |
Why?
| | Vasomotor System | 1 | 2009 | 39 | 0.080 |
Why?
| | Tetrodotoxin | 3 | 2006 | 39 | 0.080 |
Why?
| | Microcirculation | 1 | 2009 | 133 | 0.080 |
Why?
| | Gap Junctions | 1 | 2009 | 57 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 613 | 0.080 |
Why?
| | Learning | 1 | 2012 | 346 | 0.080 |
Why?
| | Allosteric Site | 1 | 2008 | 16 | 0.070 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2008 | 108 | 0.070 |
Why?
| | Drosophila Proteins | 1 | 2009 | 164 | 0.070 |
Why?
| | Cell Communication | 1 | 2009 | 277 | 0.070 |
Why?
| | Drosophila melanogaster | 1 | 2009 | 188 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2009 | 186 | 0.070 |
Why?
| | Mammals | 1 | 2009 | 241 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 2009 | 219 | 0.070 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 345 | 0.070 |
Why?
| | Purinergic Agonists | 1 | 2006 | 3 | 0.070 |
Why?
| | Purinergic P2 Receptor Agonists | 1 | 2006 | 4 | 0.070 |
Why?
| | Phenylephrine | 1 | 2006 | 71 | 0.070 |
Why?
| | Models, Chemical | 1 | 2008 | 248 | 0.070 |
Why?
| | Ligands | 1 | 2008 | 556 | 0.060 |
Why?
| | Synaptic Vesicles | 1 | 2005 | 38 | 0.060 |
Why?
| | Rod Cell Outer Segment | 1 | 2004 | 2 | 0.060 |
Why?
| | Retinaldehyde | 1 | 2004 | 5 | 0.060 |
Why?
| | NADP | 1 | 2004 | 42 | 0.060 |
Why?
| | Vitamin A | 1 | 2004 | 52 | 0.060 |
Why?
| | Protein Binding | 1 | 2008 | 1888 | 0.050 |
Why?
| | Aging | 1 | 2011 | 1611 | 0.050 |
Why?
| | Bungarotoxins | 1 | 2001 | 43 | 0.050 |
Why?
| | Axons | 1 | 2002 | 173 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1611 | 0.040 |
Why?
| | Smoking | 1 | 2008 | 1382 | 0.040 |
Why?
| | Electrophysiology | 1 | 2001 | 201 | 0.040 |
Why?
| | Motor Neurons | 1 | 2002 | 213 | 0.040 |
Why?
| | Parasympathetic Nervous System | 1 | 2000 | 24 | 0.040 |
Why?
| | Coloring Agents | 1 | 2000 | 72 | 0.040 |
Why?
| | Spinal Cord | 1 | 2002 | 344 | 0.040 |
Why?
| | Thapsigargin | 2 | 2006 | 18 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 304 | 0.030 |
Why?
| | Male | 5 | 2017 | 55396 | 0.030 |
Why?
| | Female | 3 | 2017 | 59324 | 0.020 |
Why?
| | Kinetics | 2 | 2004 | 1547 | 0.020 |
Why?
| | Humans | 2 | 2009 | 114045 | 0.020 |
Why?
| | Purinergic Antagonists | 1 | 2006 | 1 | 0.020 |
Why?
| | Purinergic P2 Receptor Antagonists | 1 | 2006 | 5 | 0.020 |
Why?
| | Receptors, Purinergic P2X | 1 | 2006 | 6 | 0.020 |
Why?
| | Pyridoxal Phosphate | 1 | 2006 | 19 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 2006 | 76 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2006 | 169 | 0.020 |
Why?
| | Cadmium | 1 | 2006 | 58 | 0.020 |
Why?
| | Brain | 1 | 2017 | 2355 | 0.020 |
Why?
| | Drug Synergism | 1 | 2006 | 315 | 0.020 |
Why?
| | Lung | 1 | 2017 | 3521 | 0.020 |
Why?
| | Rana pipiens | 1 | 2004 | 16 | 0.020 |
Why?
| | Isomerism | 1 | 2004 | 43 | 0.020 |
Why?
| | Photoreceptor Cells | 1 | 2004 | 12 | 0.020 |
Why?
| | Fluorescence Recovery After Photobleaching | 1 | 2004 | 18 | 0.020 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 102 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1003 | 0.010 |
Why?
| | Diagnostic Imaging | 1 | 2006 | 278 | 0.010 |
Why?
| | Species Specificity | 1 | 2004 | 541 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2006 | 743 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 393 | 0.010 |
Why?
| | Swimming | 1 | 2002 | 44 | 0.010 |
Why?
| | Light | 1 | 2004 | 336 | 0.010 |
Why?
| | Embryo, Nonmammalian | 1 | 2002 | 173 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2002 | 166 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2004 | 917 | 0.010 |
Why?
| | Zebrafish | 1 | 2002 | 413 | 0.010 |
Why?
| | Cell Line | 1 | 2002 | 2629 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2002 | 1696 | 0.010 |
Why?
| | Biomarkers | 1 | 2002 | 3397 | 0.010 |
Why?
|
|
Vijayaraghavan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|